Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Yahya Almodallal MBBS"'
Autor:
Jana Wieland MD, Daniel Satele BS, Yahya Almodallal MBBS, Paul Novotny MS, Stephanie L. Pritzl MD, Sumithra J. Mandrekar PhD, Aminah Jatoi MD
Publikováno v:
Journal of Patient Experience, Vol 9 (2022)
Rural patients are often underrepresented in cancer clinical trials. This is a secondary analysis of a study that tested short (2000 word) versus long (6000 word) consent forms with a focus on rurality. Among 240 patients, 89 (37%) were rural. Sevent
Externí odkaz:
https://doaj.org/article/ff33b49e34fa44ad86de9f7d86d6f11a
Autor:
Hasan Ahmad Hasan Albitar, MD, Holly Van Houten, BA, Lindsey R. Sangaralingham, MPH, Meghan Knoedler, MS, Yahya Almodallal, MBBS, Adham K. Alkurashi, MBBS, Alice Gallo De Moraes, MD, Hector Cajigas, MD, Hillary DuBrock, MD, Deepti Warad, MBBS, Nadir Demirel, MD, Michael Krowka, MD, Waleed Brinjikji, MD, Vivek N. Iyer, MD, MPH
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 5, Iss 1, Pp 55-64 (2021)
Objective: To assess the health care costs and utilization in patients with hereditary hemorrhagic telangiectasia (HHT) in the United States. Patients and Methods: Retrospective analysis of patients with HHT diagnosed between 2007 and 2017 was perfor
Externí odkaz:
https://doaj.org/article/974faeac1136453ba9e0bc4fc3958580
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 4, Iss 4, Pp 460-463 (2020)
Bevacizumab is now an emerging treatment option for severe hereditary hemorrhagic telangiectasia–related bleeding including epistaxis and gastrointestinal tract bleeding. The impact of long-term intravenous bevacizumab therapy on cardiac structure
Externí odkaz:
https://doaj.org/article/795680b1f4a94be2954797178072947b